Chondrogenesis using mesenchymal stem cells and PCL scaffolds

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Poly(epsilon-caprolactone) (PCL) is a promising biomaterial for tissue engineering scaffolds.
• Mesenchymal stem cells (MSCs) are multipotent cells with potential for cartilage regeneration.
• Surface modification of scaffolds can influence cell behavior and tissue formation.

Purpose of the Study:

• To evaluate the in vitro feasibility of porous PCL scaffolds for cartilage tissue engineering using MSCs.
• To determine the effects of various surface treatments (Pluronic F127, collagen) on PCL scaffold performance.
• To assess the chondrogenic differentiation of MSCs cultured on modified PCL scaffolds.

Main Methods:

• Porous PCL scaffolds were fabricated and modified with Pluronic F127 and/or collagen.
• Mesenchymal stem cells (MSCs) were seeded onto PCL scaffolds (pore size 100-150 µm).
• Scaffolds were cultured in vitro for 3 weeks and analyzed for DNA content, glycosaminoglycan (GAG) content, gene expression (Sox-9, COL2A1, Col1A1, Col10A1), and histology.

Main Results:

• Surface-modified PCL scaffolds (PCL/collagen, PCL/F127/collagen) exhibited higher DNA and GAG content compared to PCL-only scaffolds.
• Chondrogenic gene expression (Sox-9, COL2A1) was significantly upregulated in collagen-modified scaffolds.
• Histology confirmed enhanced MSC differentiation and extracellular matrix deposition in PCL/collagen and PCL/F127/collagen scaffolds.

Conclusions:

• Porous PCL scaffolds are suitable carriers for MSC transplantation in cartilage tissue engineering.
• Collagen-based surface modifications significantly enhance MSC chondrogenic differentiation on PCL scaffolds.
• These findings support the use of modified PCL scaffolds for developing cartilage regeneration strategies.